![]() And a lot of players are there, but what is absent is an MRNA technology transfer partner like Moderna. WHO is facilitating a MRNA vaccine hub, technology transfer hub, in South Africa and has the infrastructure, potentially, to scale up to produce some of these vaccines. But it also should mean a comprehensive technology transfer initiative, an end-to-end technology transfer initiative to low-income countries. But this should be paired up with further increase in production for international supply. OMER: So first of all, these donations will, as I said, go a long way in saving lives. has made large donations and has actually delivered on those promised donations. MARTIN: So I take your point that the U.S. But having substantial donation doesn't mean that these are sufficient efforts. donations are likely to have already saved a lot of lives. So now there are some signs that that is increasing, and it is - you know, the U.S. And one of the reasons is that high-income countries blocked those doses, in a way, for their own use, and that supply is not available or hasn't been available for a while. They were promised a pretty substantial supply in 2020, and, well, but those supplies haven't materialized. OMER: Well, the biggest problem that low-income countries have right now is supply. MARTIN: So can you explain some of the challenges that low-income countries are facing when it comes to acquiring and then administering the shots? And how does the administration's plan address this, or does it? Omer, thank you so much for joining us once again. He is the director of the Yale Institute of Global Health. The Biden administration has pledged to donate more than 1 billion doses to the global vaccination push, so we're wondering if that will make an impact and what else would. In most poorer countries, only 2% of the people have received a dose. Citizens of wealthy nations make up an overwhelming proportion of the population of the vaccinated. ![]() But when you take a closer look at the picture, you see that it's skewed. Almost 50% of the world's population has received at least one dose of a COVID-19 vaccine, which doesn't sound too bad when you consider there are more than 7 billion people on the planet. We're going to widen our lens here to talk about how to help the rest of the world cope with this crisis.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |